RIEGERT, CHRISTIAN,VOGEL, CASPAR,MUTZ, MICHAEL,DE LA CRUZ, MARILYN,KARPINSKI, PIOTR H,CISZEWSKI, LECH,SCHNEEBERGER, RICARDO
申请号：
NZ59306109
公开号：
NZ593061A
申请日:
2009.12.16
申请国别(地区):
NZ
年份:
2013
代理人:
摘要：
593061 This disclosure relates to a hemifumarate salt of 1-(4-{ 1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzyloxyimino]-ethyl} -2-ethyl-benzyl)-azetidine-3-carboxylic acid (Compound I), to pharmaceutical compositions comprising this salt, to processes for forming this salt and to its use in medical treatment. In addition, the present disclosure also relates to new polymorphic forms of the hemifumarate salt form of Compound I, as well as to pharmaceutical compositions comprising these polymorphic forms, to processes for obtaining them, and their use in medical treatment.
